Literature DB >> 27523289

Hepatic expression of cytochrome P450 in Zucker diabetic fatty rats.

So Young Park1, Chung Hyeon Kim1, Ji Yoon Lee1, Jang Su Jeon1, Min Ju Kim2, Song Hee Chae2, Hyoung Chin Kim2, Soo Jin Oh3, Sang Kyum Kim4.   

Abstract

In this study, the hepatic expression of cytochrome P450 (CYP) enzymes, including CYP1A1/2, 2B1, 2C11, 2E1, 3A1/2, and 4A, was investigated in 5-week-old (insulinresistant state) and 11-week-old (diabetic) Zucker diabetic fatty (ZDF) rats. Serum glucose and glycated hemoglobin levels were increased in 11-week-old ZDF rats, but not in 5-weekold ZDF rats. Hyperinsulinemia was observed in both age groups. The microsomal protein, total CYP, CYP reductase, CYP1A1/2, and CYP3A1 levels did not differ between 5- and 11-week-old ZDF rats and their respective control rats, while CYP4A was up-regulated in both groups. Hepatic levels of cytochrome b5, CYP2B1, CYP2C11, CYP2E1, and CYP3A2 were decreased in 5-week-old ZDF rats, but not in 11-week-old ZDF rats. Similarly, pentoxyresorufin O-depentylase, testosterone 2α- and 16α-hydroxylase, chlorzoxazone 6- hydroxylase, and midazolam 1'- and 4-hydroxylase activities were decreased only in 5-weekold ZDF rats. Based on these results, the 5-week-old ZDF rats exhibited down-regulation of the major CYP enzymes. These results suggest that hepatic expression of CYP enzymes may be dysregulated during development in ZDF rats. With the exception of CYP2B1 and CYP4A, the hepatic levels and activities of CYP were comparable between 11-week-old ZDF and control rats, suggesting that xenobiotic metabolism is normally regulated in the early diabetic state.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytochrome P450; Diabetes; Hepatic metabolism; Insulin resistance; ZDF rat

Mesh:

Substances:

Year:  2016        PMID: 27523289     DOI: 10.1016/j.fct.2016.08.010

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  9 in total

1.  Effects of insulin treatment on hepatic CYP1A1 and CYP2E1 activities and lipid peroxidation levels in streptozotocin-induced diabetic rats.

Authors:  Gökçe Kuzgun; Rahman Başaran; Ebru Arıoğlu İnan; Benay Can Eke
Journal:  J Diabetes Metab Disord       Date:  2020-08-24

2.  The Effects of AT-533 and AT-533 gel on Liver Cytochrome P450 Enzymes in Rats.

Authors:  Yanting Wu; Menghe Li; Yuying Guo; Tao Liu; Lishan Zhong; Chen Huang; Cuifang Ye; Qiuying Liu; Zhe Ren; Yifei Wang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-02-09       Impact factor: 2.441

3.  Influence of diabetes on plasma pharmacokinetics and brain bioavailability of grape polyphenols and their phase II metabolites in the Zucker diabetic fatty rat.

Authors:  Tzu-Ying Chen; Mario G Ferruzzi; Qing-Li Wu; James E Simon; Stephen T Talcott; Jun Wang; Lap Ho; George Todd; Bruce Cooper; Giulio M Pasinetti; Elsa M Janle
Journal:  Mol Nutr Food Res       Date:  2017-08-14       Impact factor: 5.914

4.  Transcriptional Profile of Kidney from Type 2 Diabetic db/db Mice.

Authors:  Haojun Zhang; Tingting Zhao; Zhiguo Li; Meihua Yan; Hailing Zhao; Bin Zhu; Ping Li
Journal:  J Diabetes Res       Date:  2017-01-23       Impact factor: 4.011

5.  Age-associated changes of cytochrome P450 and related phase-2 gene/proteins in livers of rats.

Authors:  Shang-Fu Xu; An-Ling Hu; Lu Xie; Jia-Jia Liu; Qin Wu; Jie Liu
Journal:  PeerJ       Date:  2019-08-02       Impact factor: 2.984

6.  Beneficial effects of troxerutin on metabolic disorders in non-obese model of metabolic syndrome.

Authors:  Hana Malinska; Martina Hüttl; Olena Oliyarnyk; Irena Markova; Martin Poruba; Zuzana Racova; Ludmila Kazdova; Rostislav Vecera
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

7.  High throughput metabolomics-proteomics investigation on metabolic phenotype changes in rats caused by Radix Scrophulariae using ultra-performance liquid chromatography with mass spectrometry.

Authors:  Fang Lu; Ning Zhang; Tao Ye; Hongwei Zhao; Mu Pang; Shu-Min Liu
Journal:  RSC Adv       Date:  2019-06-06       Impact factor: 4.036

Review 8.  Imbalance of Drug Transporter-CYP450s Interplay by Diabetes and Its Clinical Significance.

Authors:  Yiting Yang; Xiaodong Liu
Journal:  Pharmaceutics       Date:  2020-04-11       Impact factor: 6.321

9.  The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model.

Authors:  Martina Hüttl; Irena Markova; Denisa Miklankova; Iveta Zapletalova; Martin Poruba; Zuzana Racova; Rostislav Vecera; Hana Malinska
Journal:  Pharmaceutics       Date:  2021-12-27       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.